Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Interest & Investment Income (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Interest & Investment Income for 6 consecutive years, with $638000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 59.87% to $638000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, down 41.21% year-over-year, with the annual reading at $4.2 million for FY2025, 41.21% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $638000.0 at Strata Critical Medical, down from $1.1 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $2.3 million in Q4 2023, with the low at $4136.0 in Q1 2021.
  • Average Interest & Investment Income over 4 years is $1.5 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Interest & Investment Income tumbled 99.52% in 2021, then fell 13.91% in 2024.
  • Over 4 years, Interest & Investment Income stood at $4136.0 in 2021, then surged by 54638.88% to $2.3 million in 2023, then fell by 29.77% to $1.6 million in 2024, then tumbled by 59.87% to $638000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $638000.0, $1.1 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.